AI & the Future of Medical Writing

A two-part learning series from the inSeption Group Cooperativity Program

The conversation around AI in medical writing is moving quickly. The harder questions are starting to emerge.

Where can AI genuinely add value? Where does human judgment remain essential? How do we evaluate trust in a regulated environment, and what happens when adoption moves faster than governance?

Led by Angela Thompson, Senior Director, Medical Writing, this two-part Cooperativity series explores those questions at two levels: first by establishing a practical understanding of today's AI landscape, then by taking a deeper look at trust, governance, and the evolving role of the medical writer.

Part 1

The AI Landscape In Medical Writing: 2026

Complimentary 

Understand where we are now.

An accessible, non-technical introduction to what AI means for medical writing today. The session explores real-world AI adoption and the governance challenges emerging alongside it, demystifies key terminology, and examines practical examples, including a clinical study report case study and the risks of AI-fabricated citations.

Attendees will leave with a clearer understanding of the landscape and practical considerations for moving forward responsibly.

What we'll explore:

  • The AI landscape today
  • AI terminology without the jargon
  • Where AI can add value
  • A clinical study report case study
  • The risk of fabricated citations
  • Practical next steps

Part 2

The Evolution of Medical Writing In the Age of AI

Advanced Module | Fee Applies

Move from awareness to application.

A deeper exploration of one of the most important questions surrounding AI in regulated work: How do we know when to trust it?

This session examines the gap between AI adoption and governance, explores evolving FDA and EMA principles for credible and responsible AI use, and takes a closer look at risks such as fabricated citations. It also looks ahead to how the medical writer’s role may evolve, and what organizations should consider as they build stronger AI governance.

What we'll explore:

  • The adoption-governance gap
  • Trust and credibility
  • The FDA's risk-based credibility framework
  • FDA and EMA Good AI Practice principles
  • Fabricated citations, revisited
  • The medical writer's evolving role
  • Building stronger governance

Built to meet your team where it is

There isn't a single starting point for AI adoption, and these sessions aren't designed as one-size-fits-all presentations.

Both can be facilitated live and tailored to your team's experience level, priorities, questions, and areas of concern. Whether your organization is beginning to explore AI or already working through questions of governance and implementation, Angela can adapt the discussion to make it relevant to the people in the room.

Sessions may be delivered privately for an individual organization or offered periodically to a broader industry audience.

Meet Your Facilitator

Angela Thompson

Senior Director, Medical Writing | inSeption Group

Angela brings the perspective of an experienced medical writing leader to a conversation that is as much about people, judgment, and quality as it is about technology. Throughout both sessions, she translates a rapidly evolving topic into practical considerations for medical writers and the organizations in which they work.

Interested in bringing this conversation to your team?

Tell us a little about what you're looking for. A member of the inSeption Group Cooperativity team will follow up to discuss the sessions, customization options, and scheduling.

    Which session are you interested in?

    What type of session are you interested in?

    Learn more about the Cooperativity Program.

    Dive Deeper